Top Stories

What to expect from the FDA’s important COVID-19 vaccine meeting Thursday


An all-day regulatory meeting scheduled to take place Thursday is the next step toward the likely authorization of the first COVID-19 vaccine in the U.S.

The Food and Drug Administration this week plans to convene a meeting of its Vaccines and Related Biological Products Advisory Committee, which is made up of a group of independent medical experts, who will discuss the risks and benefits of BioNTech

and Pfizer Inc.’s

experimental COVID-19 vaccine before voting on whether the FDA should authorize the vaccine. The regulator isn’t required to follow the committee’s recommendations but often does. 



Wells Fargo CEO Scharf sees swift recovery for US economy in 2021 on vaccines

Previous article

Women are vital to achieving global ‘financial inclusion’

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories